Jones Hill Capital LP: 13F holdings
CIK 21023142026Q2
| Positions | 29 |
|---|
| Reported value | $470.4m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 29 (+3 vs prior quarter) |
|---|
| Reported value | $470.4m (+0.8%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| BMRN BIOMARIN PHARMACEUTICAL INC | 1,431,590 | $81.9m | 17.4% |
| GILD GILEAD SCIENCES INC | 343,043 | $43.3m | 9.2% |
| ARQT ARCUTIS BIOTHERAPEUTICS INC | 1,089,701 | $28.6m | 6.1% |
| MDGL MADRIGAL PHARMACEUTICALS INC | 52,545 | $28.2m | 6.0% |
| BCAX BICARA THERAPEUTICS INC | 892,621 | $26.5m | 5.6% |
| RLMD RELMADA THERAPEUTICS INC | 3,655,075 | $25.3m | 5.4% |
| TRVI TREVI THERAPEUTICS INC | 1,339,212 | $25.0m | 5.3% |
| PHARVARIS N V | 677,879 | $23.4m | 5.0% |
| XENE XENON PHARMACEUTICALS INC | 367,900 | $22.2m | 4.7% |
| ANIP ANI PHARMACEUTICALS INC | 233,808 | $19.4m | 4.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2102314")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples